Results 21 to 30 of about 1,543,151 (246)

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]

open access: yes, 2012
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Hammerstingl, Renate Maria   +6 more
core   +1 more source

Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival

open access: yesBMC Gastroenterology, 2008
Background The tumour suppressor phosphatase and tensin homolog (PTEN) is an important negative regulator of cell-survival signaling. To evaluate the correlation between PTEN expression and clinicopathological characteristics of colorectal cancer ...
Funahashi Hitoshi   +9 more
doaj   +1 more source

Colorectal cancer with synchronous liver metastases: terminology, diagnosis and management

open access: yesУкраїнський журнал клінічної хірургії, 2023
Colorectal cancer with synchronous liver metastases: terminology, diagnosis and ...
O. Yu. Usenko, A. A. Skums
doaj   +1 more source

Liver resection for colorectal metastases [PDF]

open access: yesAnnals of The Royal College of Surgeons of England, 2003
Colorectal cancer is the second commonest malignancy in the UK. Metastases to the liver occur in greater than 50% of patients and remain the biggest determinant of outcome in these patients. Liver resection is a safe procedure that achieves good long-term survival, but surgery has traditionally been limited to select groups of patients.
S R, Bramhall   +8 more
openaire   +2 more sources

Can localised 19F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? [PDF]

open access: yes, 2010
Background 5-Fluorouracil remains widely used in colorectal cancer treatment more than 40 years after its development. 19F magnetic resonance spectroscopy can be used in vivo to measure 5FU’s half-life and metabolism to cytotoxic fluoronucleotides ...
Griffiths, John R.   +17 more
core   +1 more source

Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin‐based chemotherapy for primary colorectal cancer

open access: yes, 2022
International audienceOutcome of patients who develop resectable metachronous colorectal liver metastases (CLM) after adjuvant oxaliplatin‐based chemotherapy for Stage III colorectal cancer (CRC) is not well defined and the value of preoperative ...
Pessaux, Patrick   +13 more
core   +1 more source

Surgical treatment of colorectal cancer metastases [PDF]

open access: yesScripta Medica, 2020
Background/Aim: Colorectal metastatic liver tumours are the most common secondary liver tumours. During the life of patients with colorectal tumorous, this liver metastases will develop either synchronously or metachronously in half of the patients ...
Škrbić Velimir   +3 more
doaj  

Radiofrequency Ablation for Colorectal Cancer Liver Metastases: Outcomes and Prognostic Factors Associated with Survival

open access: yes, 2023
Background: To determine the long-term outcomes of radiofrequency ablation with respect to overall survival, disease-free survival, and complications in patients with colorectal cancer liver metastases.
Okan Akhan   +11 more
core   +1 more source

Prognostic Factors after Liver Resection for Colorectal Liver Metastasis

open access: yesActa Médica Portuguesa, 2015
Introduction: Surgery is the only potentially curative treatment for patients with colorectal liver metastases, resulting in 5-year survival rates of 36–58%.
Margarida Matias   +6 more
doaj   +1 more source

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (V. 2023)

open access: yesClinical Surgical Oncology, 2023
The liver is the main target organ for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer.
Li Ren   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy